help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on May 27, 2008
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2008-0448
A more recent version of this article appeared on August 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
93/8/3037    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by McCartney, C. R.
Right arrow Articles by Stukenborg, G. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCartney, C. R.
Right arrow Articles by Stukenborg, G. J.
Related Collections
Right arrow Thyroid
Right arrow Endocrine Oncology

Submitted on February 26, 2008
Accepted on May 16, 2008

Decision analysis of discordant thyroid nodule biopsy guideline criteria

Christopher R. McCartney* and George J. Stukenborg

Division of Endocrinology and Metabolism, Department of Medicine, and Department of Public Health Sciences, University of Virginia Health System, Charlottesville, Virginia, 22908

* To whom correspondence should be addressed. E-mail: cm2hq{at}virginia.edu.

Context: Recently published guidelines are discordant regarding diagnostic approaches to small (10–14 mm) thyroid nodules.

Objective: To explore the relative desirability of alternative diagnostic approaches to small thyroid nodules using decision analysis.

Design: Four diagnostic approaches to a 10–14 mm thyroid nodule are modeled: (1) observation only, consistent with American Thyroid Association (ATA) guidelines; (2) routine fine needle aspiration biopsy (FNAB), an approach traditionally chosen by many endocrinologists and consistent with ATA guidelines; (3) FNAB only when microcalcifications are present, as recommended by Society of Radiologists in Ultrasound (SRU) guidelines; and (4) FNAB only when the nodule is hypoechoic and has at least one other ultrasonographic risk factor, as endorsed by American Association of Clinical Endocrinologists (AACE) guidelines.

Main Outcome Measures: Expected values; a priori likelihoods of prespecified outcomes; and two-way sensitivity analyses based on the utility of (1) observation only in the setting of thyroid cancer and (2) thyroid surgery for benign, asymptomatic thyroid disease.

Results: Expected values (EVs) were similar among decision alternatives modeling SRU guidelines, AACE guidelines, and routine observation (EVs from 0.912 to 0.927). Routine FNAB had the lowest EV (0.757 to 0.861), primarily related to a high a priori likelihood of having surgery for a benign nodule.

Conclusions: As a general approach to 10–14 mm thyroid nodules, routine FNAB appears to be the least desirable. This analysis offers additional data that physicians can use when choosing diagnostic approaches to small thyroid nodules based on perceived risks of delayed cancer diagnosis and unnecessary thyroid surgery.


Key words: decision analysis • fine needle aspiration biopsy • thyroid nodule • thyroid cancer • thyroid ultrasonography • Bayesian revision







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society